Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?Zacks Investment Research • 08/07/26
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?Zacks Investment Research • 08/07/26
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?Zacks Investment Research • 08/07/26
Medifast Q2 Loss Narrower Than Expected, Coach Productivity ImprovesZacks Investment Research • 08/04/26
Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 07/27/26
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026Business Wire • 07/20/26
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health SystemBusiness Wire • 07/17/26
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 06/24/26
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight ManagementGlobeNewsWire • 06/11/26
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/03/26
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year?Zacks Investment Research • 06/02/26
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to DoGlobeNewsWire • 05/21/26
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term OutcomesGlobeNewsWire • 05/21/26
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass PreservationGlobeNewsWire • 05/15/26